PUVIDA NUMBING

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: PUVIDA NUMBING
Generic name: MENTHOL 5% (W/W) NUMBING
Manufacturer: Jiangxi Yudexi Pharmaceutical Co., LTD
Product type: HUMAN OTC DRUG
SPL set ID: 4de4e317-2f4f-e5d6-e063-6394a90a0611
SPL ID: 5708eb40-9ebc-4146-e063-6394a90a0ed3
Version: 2
Effective date: 2026-07-20
Source export date: 2026-11-06
Source partition: 7
Source file: https://download.open.fda.gov/drug/label/drug-label-0007-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-11-06/824fe785252d7061429a95ddb6de517ee399ef628d34e8fdcc3591ded286ae33/drug-label-0007-of-0014.json.zip
Source manifest SHA-256: 4a7570ba105b5a039a8e1c94a85e7f085b9047a8882a35a96bf1e4516c5ffc97
Import run: 20261108T063105Z
Imported at: 2026-11-08 07:26:34

Harmonized routes table
Harmonized routes
TOPICAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		M017	openfda.application_number
brand name		PUVIDA NUMBING	openfda.brand_name
generic name		MENTHOL 5% (W/W) NUMBING	openfda.generic_name
manufacturer name		Jiangxi Yudexi Pharmaceutical Co., LTD	openfda.manufacturer_name
ndc	package	85248-172-01	openfda.package_ndc
ndc	product	85248-172	openfda.product_ndc
ndc11	package	85248017201	derived:openfda.package_ndc
rxcui		1039690	openfda.rxcui
spl id		5708eb40-9ebc-4146-e063-6394a90a0ed3	id
spl set id		4de4e317-2f4f-e5d6-e063-6394a90a0611	set_id
unii		L7T10EIP3A	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 1 matching rows.

warnings

Warnings ·For external use only ·If condition worsens, or if symptoms persist for more than 7 days or clear up and occur again within a few days, discontinue use of this product and consult a doctor ·Do not use in large quantities, particularly over raw surfaces or blistered areas ·Avoid contact with eyes. If this happens, rinse thoroughly with water

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.